Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MOEEN A SALEEM

Allopathic & Osteopathic Physicians Internal Medicine Clinical Cardiac Electrophysiology

NPI
1386696508
CMS profile
62266
Location
NAPERVILLE, IL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$81,435.11

89 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

By paying entity

PY2025 · entire year · sorted by reported total

Page 2 of 2; records 51–89 of 89 matching records. This page contains 39 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

MOEEN A SALEEM

NPI 1386696508 · CMS profile ID 62266

Allopathic & Osteopathic Physicians / Internal Medicine / Clinical Cardiac Electrophysiology

NAPERVILLE, IL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 2; records 51–89 of 89 matching records. This page contains 39 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1386696508?year=2025&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
MOEEN A SALEEM, NPI 1386696508, CMS profile ID 62266. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–89 of 89 matching records. This page contains 39 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1386696508?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). MOEEN A SALEEM, NPI 1386696508, CMS profile ID 62266. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–89 of 89 matching records. This page contains 39 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1386696508?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
MOEEN A SALEEM, NPI 1386696508, CMS profile ID 62266, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 2; records 51–89 of 89 matching records. This page contains 39 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1386696508?year=2025&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

89 matching records · $81,435.11 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 89 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–89 of 89.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Biosense Webster, Inc. $20.5108/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174055675 CMS
Biosense Webster, Inc. $1,237.5008/01/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1174159021 CMS
Boston Scientific Corporation $47.0808/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1181214870 CMS
Biosense Webster, Inc. $30.1407/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174055338 CMS
Biosense Webster, Inc. $1,125.0007/16/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1174158937 CMS
Biosense Webster, Inc. $154.0307/14/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1174055705 CMS
Biosense Webster, Inc. $29.1807/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174055324 CMS
Biosense Webster, Inc. $55.1007/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174055383 CMS
Biosense Webster, Inc. $80.8407/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174055390 CMS
Biosense Webster, Inc. $154.5207/10/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1174055527 CMS
Biosense Webster, Inc. $14.8507/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174055541 CMS
Biosense Webster, Inc. $4,950.0007/10/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1174158931 CMS
Biosense Webster, Inc. $5,175.0007/10/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1174159055 CMS
Biosense Webster, Inc. $391.4507/09/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1174055512 CMS
CARDIVA MEDICAL, INC. $18.5907/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1227276483 CMS
Biosense Webster, Inc. $7.6306/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174055681 CMS
Biosense Webster, Inc. $754.8706/26/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1174055693 CMS
Boston Scientific Corporation $20.6006/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1181214864 CMS
Boston Scientific Corporation $600.0006/05/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1181214862 CMS
Biosense Webster, Inc. $143.7906/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174055402 CMS
Boston Scientific Corporation $33.9105/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1181214866 CMS
E.R. Squibb & Sons, L.L.C. $13.8505/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184857794 CMS
CARDIVA MEDICAL, INC. $24.0605/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1227276480 CMS
Boston Scientific Corporation $30.3205/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1181214860 CMS
Medtronic, Inc. $130.6105/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1218859276 CMS
Biosense Webster, Inc. $12.6004/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174055454 CMS
Elutia, Inc. $7.5304/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1254617536 CMS
Boston Scientific Corporation $35.7904/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1181214868 CMS
Biosense Webster, Inc. $9.2003/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174055412 CMS
Boston Scientific Corporation $5,000.0002/27/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1181214854 CMS
Boston Scientific Corporation $625.0002/27/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1181214856 CMS
Boston Scientific Corporation $300.0002/20/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1181214852 CMS
Impulse Dynamics (USA) Inc. $3.2102/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223109910 CMS
Boston Scientific Corporation $32.7502/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1181214858 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $13.5002/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1173660199 CMS
Elutia, Inc. $12.8201/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1254602984 CMS
Novartis Pharmaceuticals Corporation $21.0201/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200539102 CMS
Boston Scientific Corporation $625.0001/16/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1181214848 CMS
Boston Scientific Corporation $5,000.0001/16/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1181214850 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $86,980.57 83
PY2020 $8,232.61 13
PY2021 $8,844.38 23
PY2022 $12,006.36 47
PY2023 $17,760.16 33
PY2024 $34,199.33 82
PY2025 $81,435.11 89

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $103,385.75 26
PY2024 Principal investigator $131,018.84 29
PY2023 Principal investigator $136,236.19 29
PY2022 Principal investigator $92,338.31 27
PY2021 Principal investigator $92,520.04 44
PY2020 Principal investigator $143,187.12 21
PY2019 Principal investigator $239,612.07 16

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

26 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Boston Scientific Corporation $1,163.00 12/16/2025 Non-covered Recipient Entity
CIS CLINCAL RESEARCH CORPORATION
SIMPLAAFY No dispute reported 06/30/2026 1207573460
Principal investigator 1 Janssen Research & Development, LLC $2,934.00 12/12/2025 Non-covered Recipient Entity
Crdvsclr Inst Of The S
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175223389
Principal investigator 1 Boston Scientific Corporation $13,500.00 12/09/2025 Non-covered Recipient Entity
CIS CLINCAL RESEARCH CORPORATION
SYNCHRONICITY No dispute reported 06/30/2026 1207573462
Principal investigator 1 Janssen Research & Development, LLC $5,979.00 11/19/2025 Non-covered Recipient Entity
Crdvsclr Inst Of The S
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175223498
Principal investigator 1 Boston Scientific Corporation $2,462.00 11/18/2025 Non-covered Recipient Entity
CIS CLINCAL RESEARCH CORPORATION
SIMPLAAFY No dispute reported 06/30/2026 1207573458
Principal investigator 1 Janssen Research & Development, LLC $2,645.00 11/07/2025 Non-covered Recipient Entity
Crdvsclr Inst Of The S
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175223295
Principal investigator 1 Janssen Research & Development, LLC $1,820.00 11/03/2025 Non-covered Recipient Entity
Crdvsclr Inst Of The S
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175223473
Principal investigator 1 Boston Scientific Corporation $4,502.75 10/21/2025 Non-covered Recipient Entity
CIS CLINCAL RESEARCH CORPORATION
SIMPLAAFY No dispute reported 06/30/2026 1207573456
Principal investigator 1 Boston Scientific Corporation $10,338.00 09/23/2025 Non-covered Recipient Entity
CIS CLINCAL RESEARCH CORPORATION
SIMPLAAFY No dispute reported 06/30/2026 1207573454
Principal investigator 1 Janssen Research & Development, LLC $2,908.00 09/19/2025 Non-covered Recipient Entity
Crdvsclr Inst Of The S
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175223341
Principal investigator 1 Janssen Research & Development, LLC $3,024.00 09/05/2025 Non-covered Recipient Entity
Crdvsclr Inst Of The S
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175223441
Principal investigator 1 Boston Scientific Corporation $306.50 08/26/2025 Non-covered Recipient Entity
CIS CLINCAL RESEARCH CORPORATION
SIMPLAAFY No dispute reported 06/30/2026 1207573452
Principal investigator 1 Janssen Research & Development, LLC $3,888.00 08/25/2025 Non-covered Recipient Entity
Crdvsclr Inst Of The S
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175223397
Principal investigator 1 Boston Scientific Corporation $795.00 07/22/2025 Non-covered Recipient Entity
CIS CLINCAL RESEARCH CORPORATION
SIMPLAAFY No dispute reported 06/30/2026 1207573450
Principal investigator 1 Janssen Research & Development, LLC $2,450.00 06/23/2025 Non-covered Recipient Entity
Crdvsclr Inst Of The S
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175223481
Principal investigator 1 Janssen Research & Development, LLC $2,960.00 06/20/2025 Non-covered Recipient Entity
Crdvsclr Inst Of The S
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175223416
Principal investigator 1 Boston Scientific Corporation $3,917.50 06/17/2025 Non-covered Recipient Entity
CIS CLINCAL RESEARCH CORPORATION
SIMPLAAFY No dispute reported 06/30/2026 1207573448
Principal investigator 1 Boston Scientific Corporation $1,956.00 05/27/2025 Non-covered Recipient Entity
CIS CLINCAL RESEARCH CORPORATION
SIMPLAAFY No dispute reported 06/30/2026 1207573446
Principal investigator 1 Janssen Research & Development, LLC $1,909.00 05/21/2025 Non-covered Recipient Entity
Crdvsclr Inst Of The S
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175223410
Principal investigator 1 Janssen Research & Development, LLC $5,587.00 04/23/2025 Non-covered Recipient Entity
Crdvsclr Inst Of The S
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175223349
Principal investigator 1 Boston Scientific Corporation $638.00 04/22/2025 Non-covered Recipient Entity
CIS CLINCAL RESEARCH CORPORATION
SIMPLAAFY No dispute reported 06/30/2026 1207573442
Principal investigator 1 Boston Scientific Corporation $12,800.00 04/22/2025 Non-covered Recipient Entity
CIS CLINCAL RESEARCH CORPORATION
SIMPLAAFY No dispute reported 06/30/2026 1207573444
Principal investigator 1 Janssen Research & Development, LLC $5,123.00 03/21/2025 Non-covered Recipient Entity
Crdvsclr Inst Of The S
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175223457
Principal investigator 1 Boston Scientific Corporation $2,450.00 03/11/2025 Non-covered Recipient Entity
CIS CLINCAL RESEARCH CORPORATION
OPTION No dispute reported 06/30/2026 1207573438
Principal investigator 1 Janssen Research & Development, LLC $1,300.00 02/19/2025 Non-covered Recipient Entity
Crdvsclr Inst Of The S
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175223373
Principal investigator 1 Janssen Research & Development, LLC $6,030.00 01/22/2025 Non-covered Recipient Entity
Crdvsclr Inst Of The S
A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation No dispute reported 06/30/2026 1175223289